EOLS · Healthcare · $527M
After-hours $8.000.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 60 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“매출 8,410만 달러, 전년 대비 +21% — 1분기 성장률에서 가속됐고 3분기 연속 조정 영업이익 흑자를 기록했어요.”
In the company's words · 2026 2분기 earnings call